Progress in Asia Helps Myeloma Patients Everywhere
The International Myeloma Foundation’s (IMF) 7th Annual Asian Myeloma Network (AMN) Summit in Bangkok, Thailand, marked a significant milestone in myeloma research and care, encompassing a Doctor Masterclass Program, Patient Forum, and Scientific Summit that facilitated networking among experts and addressed critical global concerns. This event provided insights that transcend Asia, showcasing the broader implications of myeloma research advancements on a global scale and emphasizing the pressing need for a worldwide cure, particularly addressing challenges in patients' access to essential tests and treatments. Dr. Bruno Paiva's keynote lecture and discussions centered on key topics such as cure versus control, immune therapies, minimal residual disease (MRD), and new therapies, sparking dialogue on the feasibility of global testing for low-level disease and immune status in myeloma.
Notably, Working Group Reports identified actionable steps to improve diagnosis, treatment, and management in Asia, while recognizing Dr. Kazuyuki Shimizu with the inaugural Asian Myeloma Network Distinguished Service Award for his significant contributions.
The summit showcased substantial advancements in AMN clinical trials and research, offering promising new treatments, not only benefiting patients in Asia but also contributing to the global myeloma community. With a commitment to extending initiatives with a potential global impact, this summit underscores the importance of international collaboration in advancing myeloma care and treatment worldwide.